ArticleOncotarget2017

Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs.

Yan-Juan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.